These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25423631)

  • 1. A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy.
    Pakzad-Vaezi K; Albiani DA; Kirker AW; Merkur AB; Kertes PJ; Eng KT; Fallah N; Forooghian F
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):521-4. PubMed ID: 25423631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
    Dong F; Yu C; Ding H; Shen L; Lou D
    Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
    Li S; Yang Y; Zou J; Zeng J; Ding C
    BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
    Hu X; Pan Q; Zheng J; Song Z; Zhang Z
    BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.
    Su L; Ren X; Wei H; Zhao L; Zhang X; Liu J; Su C; Tan L; Li X
    Retina; 2016 May; 36(5):938-43. PubMed ID: 26630313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
    Diabetic Retinopathy Clinical Research Network*
    JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
    Gupta A; Bansal R; Gupta V; Dogra MR
    Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.
    Arevalo JF; Lasave AF; Kozak I; Al Rashaed S; Al Kahtani E; Maia M; Farah ME; Cutolo C; Brito M; Osorio C; Navarro P; Wu L; Berrocal MH; Morales-Canton V; Serrano MA; Graue-Wiechers F; Sabrosa NA; Alezzandrini AA; Gallego-Pinazo R;
    Am J Ophthalmol; 2019 Nov; 207():279-287. PubMed ID: 31095954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
    Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
    Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
    Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
    Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
    Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
    Yang CS; Hung KC; Huang YM; Hsu WM
    J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy.
    Hernández-Da Mota SE; Nuñez-Solorio SM
    Eur J Ophthalmol; 2010; 20(6):1047-52. PubMed ID: 20491044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
    Pei M; Zhao X; Wan G
    Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
    Yang KB; Zhang H; Li SJ; Cao JJ; Cheng LN; Lin YX; Tian ZC; Li J; Gu F; Liu ZL
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):161-167. PubMed ID: 30668279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
    Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
    Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.
    Ozer F; Tokuc EO; Albayrak MGB; Akpinar G; Kasap M; Karabas VL
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1899-1906. PubMed ID: 35028761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study).
    Comyn O; Wickham L; Charteris DG; Sullivan PM; Ezra E; Gregor Z; Aylward GW; da Cruz L; Fabinyi D; Peto T; Restori M; Xing W; Bunce C; Hykin PG; Bainbridge JW
    Eye (Lond); 2017 Sep; 31(9):1253-1258. PubMed ID: 28498374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.